Pfizer Gets FDA Nod for Xalkori Lung Cancer Drug and 2 Other Dow Movers to Watch

Pfizer Inc. (NYSE:PFE): Current price $32.12

Pfizr announced Thursday that the Food and Drug Administration has awarded its Xalkori (crizotinib) regular approval for the treatment of patients suffering from metastatic ALK-positive non-small cell lung cancer. Xalkori was previously given accelerated approval in August 2011 because of the need for new agents for persons living with ALK-positive NSCLC. More than 6,000 patients worldwide have been treated with Xalkori, including those who received the drug in clinical trials.

pfe-20131121

McDonald’s Corp. (NYSE:MCD): Current price $97.99

McResource, the help site for McDonald’s employees, is said to be suggesting that they return holiday gifts in order to get out of debt. Screengrabs that were posted on the website of the Low Pay Is Not OK group, which advocates for higher fast food wages, read “You may want to also consider returning some of your unopened purchases that may not seem as appealing as they did.” Also reported to be in the help site’s presentation is the sentence, ”Selling some of your unwanted possessions on eBay or Craigslist could bring in some quick cash.”

mcd-20131121

AT&T Inc. (NYSE:T): Current price $35.29

Moody’s Investors Service on Thursday assigned A3 senior unsecured ratings to AT&T’s new $1.6 billion, 2.375 percent Global Notes due 2018 and $400 million floating rate notes due 2018. The rating firm said that “AT&T’s underlying A3 senior unsecured rating reflects its scale and its strong, resilient and well-diversified cash flows. The rating is also supported by AT&T’s dominant position as the #1  or #2 operator in nearly all of the key segments in which it operates.” The proceeds will be utilized for general corporate purposes including the funding of a tender offer for existing debt.

t-20131121

Don’t Miss: Will Daniele Nouy Be Appointed Europe’s Banking Regulator?

More from The Cheat Sheet